Human blood contains both the uncleaved precursor of anti-Müllerian hormone and a complex of the NH2- and COOH-terminal peptides

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 10, 2013, Pages

  Pankhurst, Michael W ^a   McLennan, Ian S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Amino and carboxy terminal anti M llerian hormone; Anti m llerian hormone enzyme linked immunosorbent assay; Boys; Furin; Menopause; Ovarian reserve; Pro anti M llerian hormone; Sex

Indexed keywords

FURIN; MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; CONTROLLED STUDY; DEGLYCOSYLATION; FEMALE; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MOLECULAR WEIGHT; POSTMENOPAUSE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROCESSING; SCHOOL CHILD; WESTERN BLOTTING;

AMINO- AND CARBOXY-TERMINAL ANTI-MÜLLERIAN HORMONE; ANTI-MÜLLERIAN HORMONE ENZYME-LINKED IMMUNOSORBENT ASSAY; BOYS; FURIN; MENOPAUSE; OVARIAN RESERVE; PRO-ANTI-MÜLLERIAN HORMONE; SEX;

ADULT; ANTI-MULLERIAN HORMONE; CHILD, PRESCHOOL; FEMALE; HEK293 CELLS; HUMANS; MALE; MIDDLE AGED; MULTIPROTEIN COMPLEXES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN PRECURSORS; PROTEIN STRUCTURE, TERTIARY; YOUNG ADULT;

EID: 84887585135     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00395.2013     Document Type: Article

References (34)

1. Akiyama T, Marques G, Wharton KA. A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing. Sci Signal 5: ra28, 2012.
2. Aksglaede L, Sørensen K, Boas M, Mouritsen a Hagen CP, Jensen RB, Petersen JH, Linneberg A Andersson A-M, Main KM, Skakkebæk NE, Juul A. Changes in anti-mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 95: 5357-5364, 2010.
3. Budzik GP, Swann DA, Hayashi A, Donahoe PK. Enhanced purification of Mullerian inhibiting substance by lectin affinity chromatography. Cell 21: 909-915, 1980.
4. Cain BM, Connolly K, Blum A, Vishnuvardhan D, Marchand JE, Beinfeld MC. Distribution and colocalization of cholecystokinin with the prohormone convertase enzymes PC1, PC2, and PC5 in rat brain. J Comp Neurol 467: 307-325, 2003.
5. Campbell BK, Clinton M, Webb R. The role of anti-mullerian hormone (AMH) during follicle development in a monovulatory species (sheep). Endocrinology 153: 4533-4543, 2012.
6. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey aZ, Gash DJ, Chow EP, Fischer R, Bertonis J, Torres G, Wallner B, Rmachandran K, Ragin R, Manganaro T, MacLaugh-lin D, Donahoe P. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45: 685-698, 1986.
7. Catlin EA, Tonnu VC, Ebb RG, Pacheco BA, Manganaro TF, Ezzell RM, Donahoe PK, Teixeira J. Mullerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung. Endocrinology 138: 790-796, 1997.
8. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimul-lerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77: 357-362, 2002.
9. Di Clemente N, Jamin SP, Lugovskoy A, Carmillo P, Ehrenfels C, Picard JY, Whitty A, Josso N, Pepinsky RB, Cate RL. Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta. Mol Endocrinol 24: 2193-2206, 2010.
10. Kurian MS, de la Cuesta RS, Waneck GL, MacLaughlin DT, Man-ganaro TF, Donahoe PK. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo. Clin Cancer Res 1: 343-349, 1995.
11. Kuroda T, Lee MM, Ragin RC, Hirobe S, Donahoe PK. Mullerian inhibiting substance production and cleavage is modulated by gonadotro-pins and steroids. Endocrinology 129: 2985-2992, 1991.
12. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81: 571-576, 1996.
13. Lorenzo HK, Teixeira J, Pahlavan N, Laurich VM, Donahoe PK, MacLaughlin DT. New approaches for high-yield purification of Mülle-rian inhibiting substance improve its bioactivity. J Chromatogr B Biomed Sci Appl 766: 89-98, 2002.
14. MacLaughlin DT, Hudson PL, Graciano AL, Kenneally MK, Ragin RC, Manganaro TF, Donahoe PK. Mullerian duct regression and anti-proliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain. Endocrinology 131: 291-296, 1992.
15. Makanji Y, Harrison CA, Stanton PG, Krishna R, Robertson DM. Inhibin A and B in vitro bioactivities are modified by their degree of glycosylation and their affinities to betaglycan. Endocrinology 148: 2309-2316, 2007.
16. Makanji Y, Temple-Smith PD, Walton KL, Harrison CA, Robertson DM. Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin a in vitro and in vivo. Endocrinology 150: 4784-4793, 2009.
17. Marchesi C, Essalmani R, Lemarie CA, Leibovitz E, Ebrahimian T, Paradis P, Seidah NG, Schiffrin EL, Prat A. Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy. J Mol Med (Berl) 89: 1103-1111, 2011.
18. Morgan K, Dennis NA, Ruffman T, Bilkey DK, McLennan IS. The stature of boys is inversely correlated to the levels of their sertoli cell hormones: do the testes restrain the maturation of boys? PLoS One 6: e20533, 2011.
19. Morgan K, Meredith J, Kuo JY, Bilkey DK, McLennan IS. The sex bias in novelty preference of preadolescent mouse pups may require testicular Mullerian inhibiting substance. Behav Brain Res 221: 304-306, 2011.
20. Nachtigal MW, Ingraham HA. Bioactivation of Mullerian inhibiting substance during gonadal development by a kex2/subtilisin-like endopro-tease. Proc Natl Acad Sci USA 93: 7711-7716, 1996.
21. Pankhurst MW, McLennan IS. Inhibin B and anti-Mullerian hormone/ Mullerian-inhibiting substance may contribute to the male bias in autism. Transl Psychiatry 2: e148, 2012.
22. Pepinsky RB, Sinclair LK, Chow EP, Mattaliano RJ, Manganaro TF, Donahoe PK, Cate RL. Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment. J Biol Chem 263: 18961-18964, 1988.
23. Picard JY, Goulut C, Bourrillon R, Josso N. Biochemical analysis of bovine testicular anti-Müllerian hormone. FEBS Lett 195: 73-76, 1986.
24. Picard JY, Tran D, Josso N. Biosynthesis of labelled anti-Mullerian hormone by fetal testes: evidence for the glycoprotein nature of the hormone and for its disulfide-bonded structure. Mol Cell Endocrinol 12: 17-30, 1978.
25. Ragin RC, Donahoe PK, Kenneally MK, Ahmad MF, MacLaughlin DT. Human Mullerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects. Protein Expr Purif 3: 236-245, 1992.
26. Stawowy P, Marcinkiewicz J, Graf K, Seidah N, Chretien M, Fleck E, Marcinkiewicz M. Selective expression of the proprotein convertases furin, pc5, and pc7 in proliferating vascular smooth muscle cells of the rat aorta in vitro. J Histochem Cytochem 49: 323-332, 2001.
27. Tarentino A, Plumber T. Enzymatic deglycosylation of asparagine-linked glycans: Purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Methods En-zymol 230: 44-57, 1994.
28. Veinot JP, Prichett-Pejic W, Picard P, Parks W, Schwartz R, Seidah NG, Chretien M. Implications of proprotein Convertase 5 (PC5) in the arterial restenotic process in a porcine model. Cardiovasc Pathol 13: 241-250, 2004.
29. Villeneuve P, Seidah NG, Beaudet A. Immunohistochemical distribution of the prohormone convertase PC5-A in rat brain. Neuroscience 92: 641-654, 1999.
30. Visser JA, Schipper I, Laven JS, Themmen AP. Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol 8: 331-341, 2012.
31. Wang PY, Koishi K, McGeachie AB, Kimber M, Maclaughlin DT, Donahoe PK, McLennan IS. Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc Natl Acad Sci USA 102: 16421-16425, 2005.
32. Wang PY, Protheroe A, Clarkson AN, Imhoff F, Koishi K, McLennan IS. Mullerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci USA 106: 7203-7208, 2009.
33. Wilson CA, Di Clemente N, Ehrenfels C, Pepinsky RB, Josso N, Vigier B, Cate RL. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily. Mol Endocrinol 7: 247-257, 1993.
34. Wittmann W, McLennan IS. The male bias in the number of Purkinje cells and the size of the murine cerebellum may require Mullerian inhibiting substance/anti-Mullerian hormone. J Neuroendocrinol 23: 831-838, 2011.